U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 19

EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 19

Summary

Idiopathic generalized epilepsy-19 (EIG19) is an autosomal dominant seizure disorder characterized by onset of variable types of seizures in the first two decades of life. Generalized tonic-clonic seizures are most common, but others include febrile, atypical absence, atonic, and myoclonic seizures (Fan et al., 2024). For a general phenotypic description and a discussion of genetic heterogeneity of idiopathic generalized epilepsy, see EIG (600669). [from OMIM]

Genes See tests for all associated and related genes

  • Also known as: EIG19, USP21, USP25
    Summary: ubiquitin specific peptidase 25

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.